Subtype

Malignant Uterine Neoplasm

824 active trials7 approved drugs44 evidence items

NCIt: C3552
DOID: 363

Clinical trials

Registered studies

3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 824
Recruiting: 456
Ph III recruiting: 55
Growth YoY: −3.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

No study matches these filters